Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/8/2025

Preventative Medicine Laboratory Tests

Core Laboratory Tests

  • The American College of Preventative Medicine recommends a comprehensive set of laboratory tests, including complete blood count, comprehensive metabolic panel, lipid profile, hemoglobin A1C, and urinalysis as core tests, with additional specialized testing based on age, risk factors, and specific conditions 1
  • Complete blood count (CBC) with differential is recommended to screen for anemia, infection, and blood disorders 1
  • Comprehensive metabolic panel (CMP) is recommended to assess kidney function, liver function, and electrolyte balance 1
  • Lipid profile, including total cholesterol, LDL, HDL, and triglycerides, is recommended to assess cardiovascular risk 1, 2
  • Hemoglobin A1C is recommended to screen for diabetes and prediabetes 1
  • Urinalysis with albumin-to-creatinine ratio is recommended to screen for kidney disease and urinary tract infections 1, 2
  • Blood pressure measurement is recommended at every visit 1

Age and Risk-Based Screening

  • Annual testing for adults with BMI ≥25 kg/m² with one or more risk factors (first-degree relative with diabetes, high-risk race/ethnicity, history of cardiovascular disease, hypertension, HDL <35 mg/dL, triglycerides >250 mg/dL, polycystic ovary syndrome, physical inactivity) is recommended for diabetes screening 1, 2
  • Yearly testing for patients with prediabetes (A1C 5.7-6.4%) is recommended 1
  • Testing beginning at age 35 and repeating every 3 years if normal for all other adults is recommended for diabetes screening 1
  • Fasting lipid profile every 6-12 months is recommended for cardiovascular screening 1
  • Abdominal ultrasonography once for men aged 65-75 years who have ever smoked is recommended for cardiovascular screening 1

HIV and STI Screening

  • HIV testing with fourth- or fifth-generation laboratory-based antigen-antibody assay is recommended for patients at risk or as part of routine screening 3, 4
  • Screening for other sexually transmitted infections is recommended for patients at risk or as part of routine screening 3
  • Screening for syphilis is recommended for patients at risk or as part of routine screening 3
  • Hepatitis screening (Hepatitis B surface antigen, antibody to hepatitis B surface antigen or to hepatitis B core antigen, antibody to hepatitis C virus, total hepatitis A antibody) is recommended for patients at risk or as part of routine screening 3

Special Considerations for Older Adults

  • Thyroid-stimulating hormone (TSH) testing is recommended, particularly for women and older adults 1
  • Bone densitometry is recommended for postmenopausal women and men age ≥50 years 1
  • Functional performance assessment is recommended for adults ≥65 years 1, 2
  • Screening for cognitive impairment is recommended in older adults with risk factors 1

Medication-Specific Monitoring

  • Vitamin B12 levels are recommended for patients on metformin 1, 2
  • Serum potassium levels are recommended for patients on ACE inhibitors, ARBs, or diuretics 1, 2
  • Liver function tests are recommended for patients on certain medications that can affect the liver 5
  • Medication-specific monitoring is recommended based on individual drug profiles 5

Disease-Specific Monitoring

  • For patients with diabetes, A1C is recommended every 3-6 months 2
  • For patients with diabetes, lipid profile is recommended annually 2
  • For patients with diabetes, urinary albumin-to-creatinine ratio is recommended annually 2
  • For patients with diabetes, serum creatinine and estimated glomerular filtration rate are recommended annually 2
  • For patients with HIV, CD4 cell count and percentage are recommended 3, 6
  • For patients with HIV, HIV viral load is recommended 3, 6
  • For patients with HIV, HIV resistance testing is recommended (genotype determination preferred in antiretroviral-naive patients) 3
  • For patients with HIV, screening for co-infections (tuberculosis, viral hepatitis, etc.) is recommended 3, 6

Special Population Considerations

  • For obesity management, basic laboratory evaluation should include a comprehensive metabolic panel, fasting lipid profile, and thyroid function tests 7
  • For obesity management, screen for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40–70 years with overweight or obesity 7
  • For cancer screening and monitoring, disease-specific monitoring protocols should be followed for patients with cancer or at high risk 8
  • For multiple myeloma monitoring, CBC, serum chemistry for creatinine, albumin, LDH, calcium, and β-2 microglobulin are recommended 8